HLIB Research places 'Buy' call on UMediC on rising production capacity

KUALA LUMPUR: UMediC Group Bhd (UMC) is expected to achieve core profit after taxation and minority interests (PATMI) growth of about 25 per cent in the financial year 2025 (FY25), driven by an increase in production capacity for HydroX.